Insiders Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 16:00:02 2026-08-07 EDT			5-day change	1st Jan Change
352.47 ^USD	+2.93%		+7.88%	+16.33%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Insiders

25-09-30	Bio-Rad Laboratories, Inc. Announces Demise of Alice N. Schwartzas, Co-Founder and Director	CI
25-07-28	Bio-Rad Laboratories, Inc. Appoints Rajat Mehta as Executive Vice President, Global Commercial Operations, Effective August 4, 2025	CI
24-09-10	Bio-rad Laboratories Insider Sold Shares Worth $989,815, According to a Recent SEC Filing	MT
24-08-20	Bio-Rad Laboratories Names Jon DiVincenzo COO	MT
24-08-20	Bio-Rad Laboratories, Inc. Announces Executive Changes	CI
24-05-30	Bio-Rad Laboratories, Inc. Appoints Anette Engelhardt as Executive Vice President and President of Clinical Diagnostics Group, Effective June 10, 2024	CI
24-04-26	Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	CI
24-04-10	Bio-Rad Laboratories COO Andrew Last to Retire in September	MT
24-04-10	Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	CI
24-03-20	Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	CI
24-02-14	Bio-Rad Laboratories, Inc. Appoints Norman Schwartz as Principal Financial Officer	CI
23-12-07	Bio-Rad Laboratories, Inc. Announces Resignation of Dara Grantham Wright as Executive Vice-President and President, Effective January 12, 2024	CI
23-10-17	Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Executive Vice-President and Principal Financial Officer, Effective November 6, 2023	CI
23-10-17	Bio-Rad Laboratories, Inc. Announces Resignation of Ilan Daskal, Chief Financial Officer, Effective November 6, 2023	CI
23-08-31	Bio-Rad Laboratories EVP Ernst Sells 2,350 Shares for $929,667	MT
23-08-25	Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective September 18, 2023	CI
22-08-25	Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	MT
22-03-28	Bio-Rad Laboratories, Inc. Announces Board Changes	CI
21-12-16	Bio-Rad Laboratories, Inc. Announces Executive Changes	CI
21-10-04	Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective January 4, 2022	CI
20-04-06	Bio-Rad Laboratories, Inc. Announces Executive Changes	CI
20-03-02	James R. Stark, the Vice-President, Controller and Principal Accounting Officer of Bio-Rad Laboratories, Inc. Plans to Retire , Effective June 5, 2020	CI
20-01-06	Bio-Rad Laboratories, Inc. Announces Executive Changes	CI
19-08-23	Bio-Rad Laboratories, Inc. Announces Executive Changes	CI
19-04-22	Bio-Rad Laboratories, Inc. Appoints Andrew Last as Executive Vice President and Chief Operating Officer	CI